ArticleHepatology international2021

Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma.

David Wai Meng Tai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.